Duopharma Biotech Berhad (7148.KL)

Malaysia · Healthcare · MYR

Key financials

ROE: 11.93%; 2025 (actual)
ROA: 6.19%; 2025 (actual)
Gross Margin: 38.98%; 2025 (actual)
Net Margin: 9.39%; 2025 (actual)
Total Assets: MYR 1,448.31M; 2025 (actual)
Net Income: MYR 87.46M; 2025 (actual)
Valuation: MYR 1,163.66M; 2026 (forecast)
Stock Price: MYR 1.21; 2026 (forecast)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026 (forecast)	2027	2028	2029	2030	2031
ROE	11.93%	13.55%	13.18%	12.9%	13.3%	13.42%	12.51%
Sector average	-	5.37%	4.99%	3.81%	0.37%	-40.36%	13.39%
ROA	6.19%	7.2%	7.32%	7.51%	8.02%	8.36%	8.07%
Sector average	-	3.23%	3.16%	3.2%	3.32%	3.29%	3.43%

Amounts in MYR (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.

Want the full financial forecast report for Duopharma Biotech Berhad? It covers the balance sheet, income statement and Equlion model projections.

Net Margin	9.39%	10.95%	11.39%	11.28%	11.34%	11.66%	11.61%
Sector average	-	2.37%	2.59%	2.69%	2.79%	2.95%	3.23%

Total Assets	MYR 1,448.31M	MYR 1,457.72M	MYR 1,572.58M	MYR 1,722.07M	MYR 1,906.55M	MYR 2,106.99M	MYR 2,305.10M
Sector average	-	MYR 2,920.17M	MYR 3,109.01M	MYR 3,342.03M	MYR 3,639.75M	MYR 3,975.91M	MYR 4,522.10M

Net Income	MYR 87.46M	MYR 104.56M	MYR 110.92M	MYR 123.69M	MYR 145.45M	MYR 167.81M	MYR 178.09M
Sector average	-	MYR 110.52M	MYR 128.59M	MYR 144.40M	MYR 169.64M	MYR 195.28M	MYR 227.48M

Valuation	-	MYR 1,163.66M	MYR 1,211.03M	MYR 1,260.26M	MYR 1,311.10M	MYR 1,363.66M	MYR 1,418.50M
Sector average	-	MYR 5,741.00M	MYR 5,975.94M	MYR 6,220.71M	MYR 6,476.72M	MYR 3,893.31M	MYR 4,402.28M

Stock Price	-	MYR 1.21	MYR 1.26	MYR 1.31	MYR 1.36	MYR 1.42	MYR 1.47
Sector average	-	MYR 0.88	MYR 0.91	MYR 0.95	MYR 0.99	MYR 1.06	MYR 1.19